4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-359255
Director sold 103,606 shares at an average $118.25 ($12,251,411)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MAHONEY DAVID L Director | 2026-08-18 | Sale 10b5-1 | −4,984 | $117.47 | $585,478 | 1,232,161 | I: show line 1 in the form |
| MAHONEY DAVID L Director | 2026-08-18 | Sale 10b5-1 | −91,167 | $118.24 | $10,779,367 | 1,140,994 | I: show line 2 in the form |
| MAHONEY DAVID L Director | 2026-08-18 | Sale 10b5-1 | −7,055 | $118.88 | $838,710 | 1,133,939 | I: show line 3 in the form |
| MAHONEY DAVID L Director | 2026-08-18 | Sale 10b5-1 | −400 | $119.64 | $47,855 | 1,133,539 | I: show line 4 in the form |
| Open-market sales · 103,606 sh · avg $118.25 · $12,251,411 | |||||||
Loading xslF345X06/ownership.xml…